• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

DaVita (DVA)

Common Stock
Sell: $154.70|Buy: $158.00|Change: 3.76 (2.46%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.

Address

2000 16th Street
Denver
CO
USA
80202

Telephone

+1 720 631-2100

Website

https://www.davita.com

Sector 

Healthcare

Forecast key dates

NameKey Date
DaVita Inc Annual Report for 20262027-02-11T00:00:00
DaVita Inc Fourth Quarter Earnings Conference Call for 20262027-02-02T17:00:00
DaVita Inc Fourth Quarter Earnings Results for 20262027-02-02T00:00:00
DaVita Inc Third Quarter Earnings Conference Call for 20262026-10-29T17:00:00
DaVita Inc Third Quarter Earnings Results for 20262026-10-29T00:00:00
DaVita Inc Second Quarter Earnings Conference Call for 20262026-08-05T17:00:00
DaVita Inc Second Quarter Earnings Results for 20262026-08-05T00:00:00
DaVita Inc Annual General Meeting for 20262026-06-05T10:00:00
DaVita Inc First Quarter Earnings Conference Call for 20262026-05-12T17:00:00
DaVita Inc First Quarter Earnings Results for 20262026-05-12T00:00:00
TD Cowen's 46th Annual Health Care Conference2026-03-02T11:50:00

Previous key dates

NameKey Date
TD Cowen's 46th Annual Health Care Conference2026-03-02T11:50:00
DaVita Inc Annual Report for 20252026-02-11T00:00:00
DaVita Inc Fourth Quarter Earnings Conference Call for 20252026-02-02T17:00:00
DaVita Inc Fourth Quarter Earnings Results for 20252026-02-02T00:00:00
Wolfe Research Healthcare Conference2025-11-17T11:20:00
DaVita Inc Third Quarter Earnings Conference Call for 20252025-10-29T17:00:00
DaVita Inc Third Quarter Earnings Result for 20252025-10-29T00:00:00
DaVita Inc Second Quarter Earnings Conference Call for 20252025-08-05T17:00:00
DaVita Inc Second Quarter Earnings Results for 20252025-08-05T00:00:00
DaVita Inc Annual General Meeting for 20252025-06-05T10:00:00
DaVita Inc First Quarter Earnings Conference Call for 20252025-05-12T17:00:00
DaVita Inc First Quarter Earnings Result for 20252025-05-12T00:00:00
Barclays Global Healthcare Conference 20252025-03-11T09:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.